Yilifang Biotech.
Shenzhen Yilifang Biotechnology Co., Ltd. was
established in 2013. It is a national high-tech enterprise integrating the
development, production and sales of precision medical in vitro diagnostic
reagents. The companychr(34)s research and development team consist of scientific
researchers from top international institutions and domestic translation
medical elites, including high-quality talents of national leading talents, Class
B peacock talents, and reserve talents. Targeting existing "pain
points" in the market, Yilifang links with domestic and foreign
cutting-edge technologies and committed to creating good products that can
truly address the demands form the market.
Product architecture
From the major diseases that the society needs
to solve urgently, Yilifang has built products in four major sectors. It has
successfully developed more than 20 Class III in vitro diagnostic products, and
its products have gradually entered the national registration stage.
Yilifang was established in the new era of
precision medicine. Since its inception, Yilifang has been pragmatic and
prudent in its work style. It has vigorously coordinated development in talent
cultivation, research and development innovation, safety compliance, and
quality system construction, etc. It has also made initial achievements. In
terms of talent training, a high-quality elite team has been created. Among the
current members, about 50% of employees have masterchr(34)s degrees, and more than
10% have doctoral degrees. A platform, a post-doctoral practice and innovation
base, for sustainably meeting the needs of high-end talents-a postdoctoral
practice innovation base has been established. On the other hand, Yilifang
adheres to the idea of quality as the basis and regulations as the
norm, and has established a comprehensive system in terms of quality and
safety, fire safety and environmental protection. In terms of technological
innovation, Yilifang has obtained national, provincial, and municipal department’
recognition and awards at various levels through independent research and
development. In 2017, as the only representative of the Shenzhen In vitro
Diagnostic Reagent Enterprise Group, it was promoted to the National Innovation
and Entrepreneurship Competition.
WeChat official account
